Gruenenthal GmbH
PolandAll medications by this manufacturer
-
Palexia
Form: tablets, film-coated
Active substance Dosage tapentadol 100 mg ATC: N02AX06
-
Palexia
Form: tablets, film-coated
Active substance Dosage tapentadol 50 mg ATC: N02AX06
-
Palexia
Form: tablets, film-coated
Active substance Dosage tapentadol 75 mg ATC: N02AX06
-
Palexia
Form: solution, oral
Active substance Dosage tapentadol hydrochloride 4.66 mg/ml ATC: N02AX06
-
Palexia
Form: solution, oral
Active substance Dosage tapentadol hydrochloride 23.3 mg/ml ATC: N02AX06
-
Palexia retard
Form: tablets, prolonged release
Active substance Dosage tapentadol 100 mg ATC: N02AX06
-
Palexia retard
Form: tablets, prolonged release
Active substance Dosage tapentadol 150 mg ATC: N02AX06
-
Palexia retard
Form: tablets, prolonged release
Active substance Dosage tapentadol 200 mg ATC: N02AX06
-
Palexia retard
Form: tablets, prolonged release
Active substance Dosage tapentadol 250 mg ATC: N02AX06
-
Palexia retard
Form: tablets, prolonged release
Active substance Dosage tapentadol hydrochloride 29.12 mg ATC: N02AX06
-
Palexia retard
Form: tablets, prolonged release
Active substance Dosage tapentadol 50 mg ATC: N02AX06